Xpress Genomics

Xpress Genomics is a Stockholm-based, private contract research organization (CRO) offering a suite of NGS services built around a proprietary, automated platform for full-length scRNA-seq. Founded by leading genomics researchers from Karolinska Institutet, the company targets academic and biopharma researchers needing scalable, high-quality sequencing data. It operates a services-based business model, having completed over 400 projects for 120+ customers across 13 countries, positioning it in the rapidly growing genomics and spatial biology markets. The company is in an early revenue stage, leveraging its academic roots and technological innovation to capture market share.

Proprietary automated platform integrating robotics and custom software for scalable, full-length single-cell RNA sequencing (Xpress-seq) and other omics workflows.

Xpress Genomics competes in the crowded NGS services market against large global players (e.g., Novogene, Azenta, Eurofins), specialized genomics CROs, and academic core facilities. Its differentiation lies in its proprietary full-length scRNA-seq automation, academic-founder credibility, and focus on combining high data quality with scalability for research cohorts.